The companies behind a drug that was recently approved to treat symptoms of agitation in Alzheimer's patients are facing a class-action lawsuit over alleged 'harmful side effects.'
911 News Blogger Template is Designed Theme for Giving Enhanced look Various Features are available Which is designed in User friendly to handle by Piki Developers. Simple and elegant themes for making it more comfortable